Amphion Innovations PLC Director/PDMR Shareholding (3471E)
February 09 2015 - 2:01AM
UK Regulatory
TIDMAMP
RNS Number : 3471E
Amphion Innovations PLC
09 February 2015
Amphion Innovations plc
("Amphion" or "the Company")
(LSE: AMP)
Directors' Dealings
Directors Receive Shares in Lieu of Fees
Amphion Innovations, a developer of medical, life science, and
technology businesses, announces that the Company has today issued
344,471 ordinary shares, representing 0.23% of the enlarged issued
share capital, to certain of its Board members as their directors'
fees for the first quarter of 2015, priced at 3.250 pence, being
the average of the closing mid-market price for the five days
leading up to the market close on 5 February 2015. Following this
issue, the directors' shareholdings in the Company are as
follows:
Director Number of New Shares Total Shareholding Percentage of voting rights
Miroslaw Izienicki 81,250 183,333 0.123%
R. James Macaleer 216,346 25,811,881 17.367%
Gerard Moufflet 46,875 1,086,458 0.731%
Admission of the 344,471 new ordinary shares, ranking pari passu
with the existing ordinary shares, is expected on 16 February 2015.
Following this allotment the total issued share capital of the
Company will increase to 148,622,977 ordinary shares with each
share holding one voting right.
For further information please contact:
Amphion Innovations plc
Charlie Morgan
+1 212 210 6224
Yellow Jersey PR
Dominic Barretto / Fiona Walker
+44 7768 537 739
Plumtree Capital Limited (Financial Advisor)
Stephen Austin
London: +44 207 183 5860
New York: +1 646 652 0799
Panmure Gordon Limited (Nominated Advisor and Broker)
Freddy Crossley / Fred Walsh / Duncan Monteith (Corporate
Finance)
Charlie Leigh-Pemberton (Corporate Broking)
+44 020 7886 2500
About Amphion Innovations plc
Amphion Innovations is a developer of medical, life science and
technology businesses.
We use our extensive experience in company building to invest
and build shareholder value in high growth companies in the US and
UK. Amphion has significant shareholding in 7 Partner Companies
developing proven technologies targeting substantial commercial
marketplaces. The Amphion model has been refined to optimise the
commercialisation of patents and other intellectual property within
the Partner Companies. The Partner Companies collectively own or
control over 200 separately identified pieces of intellectual
property, a number which grows rapidly each year.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSVQLFBELFXBBL
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Apr 2023 to Apr 2024